Fangfei Xiao

415 total citations
20 papers, 284 citations indexed

About

Fangfei Xiao is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Fangfei Xiao has authored 20 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in Fangfei Xiao's work include Gut microbiota and health (11 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Inflammatory Bowel Disease (4 papers). Fangfei Xiao is often cited by papers focused on Gut microbiota and health (11 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Inflammatory Bowel Disease (4 papers). Fangfei Xiao collaborates with scholars based in China, Netherlands and Belgium. Fangfei Xiao's co-authors include Yizhong Wang, Ting Zhang, Fang Dong, Xiaolu Li, Guangjun Yu, Youran Li, Xufei Wang, Zhanju Liu, Yongmei Xiao and Ting Ge and has published in prestigious journals such as Nutrients, Journal of Food Science and Frontiers in Pharmacology.

In The Last Decade

Fangfei Xiao

18 papers receiving 280 citations

Peers

Fangfei Xiao

GENET

EPIDE

Sakari Pöysti Finland

Julia Eckenberger Ireland

Claudia Moresi Switzerland

Giulia Pignataro Italy

Lie Zheng China

Rohini Emani Finland

Aida Mayorgas Spain

Gráinne Lennon Ireland

Fabio Del Zompo Italy

Yu Anne Yap Australia

Sakari Pöysti Finland

Fangfei Xiao

260 ×1.4

85 ×1.1

GENET

88 ×1.3

54 ×1.1

27 ×0.7

EPIDE

Citations per year, relative to Fangfei Xiao Fangfei Xiao (= 1×) peers Sakari Pöysti

Countries citing papers authored by Fangfei Xiao

Since Specialization

Citations

This map shows the geographic impact of Fangfei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfei Xiao more than expected).

Fields of papers citing papers by Fangfei Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfei Xiao. The network helps show where Fangfei Xiao may publish in the future.

Co-authorship network of co-authors of Fangfei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfei Xiao. A scholar is included among the top collaborators of Fangfei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfei Xiao. Fangfei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Rong, Cuili Xue, Xiaolu Li, et al.. (2025). Profiling of volatile organic compounds in clinical isolate cultures and stools from children with Clostridioides difficile infection by HS-SPME-GC-MS. Journal of Breath Research. 19(4). 46008–46008.

Xiao, Pei, Youran Li, Xiaolu Li, et al.. (2025). Long-term safety of fecal microbiota transplantation in Chinese children from 2013 to 2023: a single-center retrospective study. BMC Microbiology. 25(1). 152–152. 1 indexed citations

Wang, Xufei, Xiaoduo Pan, Fangfei Xiao, et al.. (2025). Donor Human Milk Bacterial Microbiota Composition is Shaped by Breastfeeding Mode. Journal of Human Lactation. 41(3). 359–370.

Li, Youran, Pei Xiao, Rong Cao, et al.. (2024). Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder. Frontiers in Pediatrics. 12. 1369823–1369823. 13 indexed citations

Li, Xiaolu, Yizhong Wang, Rong Cao, et al.. (2024). Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China. Infection and Drug Resistance. Volume 17. 329–339. 4 indexed citations

Wang, Xufei, Fang Dong, Fangfei Xiao, et al.. (2024). Probiotic properties and the ameliorative effect on DSS‐induced colitis of human milk–derived Lactobacillus gasseri SHMB 0001. Journal of Food Science. 89(5). 3078–3093. 3 indexed citations

Li, Xiaolu, Fangfei Xiao, Xufei Wang, et al.. (2024). Gut Microbial and Metabolic Features Associated With Clostridioides difficile Infection Recurrence in Children. Open Forum Infectious Diseases. 11(9). ofae506–ofae506. 1 indexed citations

Wang, Yizhong, Yanming Lu, Hui Hu, et al.. (2023). Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant. World Journal of Pediatrics. 19(5). 478–488. 5 indexed citations

Wang, Yizhong, Fangfei Xiao, Xufei Wang, et al.. (2023). F. prausnitzii-derived extracellular vesicles attenuate experimental colitis by regulating intestinal homeostasis in mice. Microbial Cell Factories. 22(1). 235–235. 22 indexed citations

10.

Wang, Yizhong, Honghong Liu, Dong Fang, et al.. (2023). Altered gut microbiota and microbial metabolism in children with hepatic glycogen storage disease: a case-control study. Translational Pediatrics. 12(4). 572–586. 4 indexed citations

11.

Xiao, Fangfei, Yizhong Wang, Thomas Ludwig, et al.. (2023). Generation and application of a convolutional neural networks algorithm in evaluating stool consistency in diapers. Acta Paediatrica. 112(6). 1333–1340. 6 indexed citations

12.

Xiao, Fangfei, Xuefeng Gao, Hui Hu, et al.. (2022). Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities. Nutrients. 14(21). 4463–4463. 11 indexed citations

13.

Xiao, Fangfei, Fang Dong, Xiaolu Li, et al.. (2022). Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Frontiers in Pharmacology. 13. 902337–902337. 39 indexed citations

14.

Dong, Fang, Fangfei Xiao, Xiaolu Li, et al.. (2022). Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice. Journal of Translational Medicine. 20(1). 33–33. 67 indexed citations

15.

Li, Xiaolu, Fangfei Xiao, Youran Li, et al.. (2022). Characteristics and management of children with Clostridioides difficile infection at a tertiary pediatric hospital in China. The Brazilian Journal of Infectious Diseases. 26(4). 102380–102380. 5 indexed citations

16.

Xiao, Fangfei, Yizhong Wang, Fang Dong, Xiaolu Li, & Ting Zhang. (2021). Congenital hepatic fibrosis in a young boy with congenital hypothyroidism: A case report. World Journal of Clinical Cases. 9(6). 1475–1482. 1 indexed citations

17.

Dong, Fang, Fangfei Xiao, Ting Ge, et al.. (2021). Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease. Frontiers in Pediatrics. 9. 678390–678390. 4 indexed citations

18.

Xiao, Fangfei, et al.. (2021). Case Report: Pediatric Recurrent Acute Liver Failure Caused by Neuroblastoma Amplified Sequence (NBAS) Gene Mutations. Frontiers in Pediatrics. 8. 607005–607005. 7 indexed citations

19.

Wang, Yizhong, Xuefeng Gao, Xinyue Zhang, et al.. (2021). Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease. Gut Microbes. 13(1). 1–18. 87 indexed citations

20.

Xiao, Fangfei, et al.. (1987). Comparative efficacy of thienpydin, pyrantel pamoate, mebendazole and albendazole in treating ascariasis and enterobiasis.. PubMed. 100(11). 928–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact